Objective Experimental studies have suggested that autoimmunity is involved in
atherosclerosis and provided evidence that both protective and pro-atherogenic immune …

Antiphospholipid antibodies (aPL) are associated with vascular events, but the magnitude of
this risk, alone, or in combination with other atherogenic and thrombophilic risk factors …

Objective. We studied antiphospholipid antibodies (aPL) in blood samples from a cohort of
individuals followed for thrombosis to determine whether the persistent presence of …

Objective: To determine the distribution of different antiphospholipid antibodies (APL-Ab)
and their association with thrombosis in patients with autoimmune diseases. Methods …

Background: In recent years it became apparent that mortality in patients with generalized
autoimmune diseases like Antiphospholipid Syndrome (APS) and/or Systemic Lupus …

Background: The role of autoimmune factors in the etiology of coronary artery disease (CAD)
was suggested in numerous studies but has not been definitively determined. Objectives: To …

We compared several “new” risk factors (autoantibodies to oxidatively modified low density
lipoprotein (LDL), sialic acid content of LDL, bilirubin and C-reactive protein) with …

INTRODUCTION: The apolipoproteinB (apoB)/apolipoproteinA-I (apoA-I) ratio mirrors the
number of pro-atherogenic and anti-atherogenic lipoprotein particles. This ratio may carry …

Abstract Autoantibodies to apolipoprotein/A‐1 (anti‐ApoA‐1 IgG) have pro‐atherogenic
properties in patients at high cardiovascular risk, but its prevalence in patients with end …

Abstract Objectives Apolipoprotein A-1 (ApoA-1) is a protein fraction of the high-density
lipoproteins with anti-inflammatory and antioxidant properties that play a major role in …